When moving to immunologic parameters, uILD patients showed a significant reduction in IgG and IgA levels at CVID diagnosis if compared to controls, similarly to the GLILD group, and as for GLILD required higher dosage of IgRT than controls in order to achieve similar IgG trough levels (Supplementary Figure 1). This evidence concerns the gene CD79A and common variable immunodeficiency.